Bio-Works Technologies
Bio-Works Receives Order Worth SEK 2.4 Million from New European Customer in Vaccine Production
REG
"We see it as a strong endorsement that a new player in vaccine production chooses Bio-Works as a supplier. This strengthens our position in the European market," says Lone Carlbom, CEO of Bio-Works Technologies AB.
The delivery concerns products used in the production process and represents a potential for long-term collaboration.
This disclosure contains information that Bio-Works Technologies AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014) and the Swedish Securities Markets Act (2007:528). The information was submitted for publication, through the agency of the contact person, on 29-04-2025 16:04 CET.
| Datum | 2025-04-29, kl 16:04 |
| Källa | Cision |
Alla Aktier tipsar: Har du redan ett konto på Avanza? Varför inte skapa ett på Nordnet också och jämföra funktioner, courtage mm. Det tar inte lång tid, du fixar det direkt här med BankID
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet